KEGG   DRUG: D08985Help
Entry
D08985                      Drug                                   

Name
Reslizumab (USAN)
Product
Activity
Treatment of bronchial asthma as well as a pharmacological tool to elucidate the role of IL-5 in human eosinophilic diseases
Remark
ATC code: 
Comment
Monoclonal antibody
Target
interleukin 5 (IL-5) [HSA:3567] [KO:K05428]
  Pathway
Cytokine-cytokine receptor interaction
Jak-STAT signaling pathway
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
    R03DX Other systemic drugs for obstructive airway diseases
     R03DX08 Reslizumab
      D08985  Reslizumab (USAN)
Target-based classification of drugs [BR:br08310]
 Cytokines
  Class I cytokines
   IL-5
    Reslizumab
     D08985  Reslizumab (USAN)
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D08985
BRITE hierarchy
Other DBs
CAS: 
241473-69-8
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system